There was a trend of reduced pII cell proliferation (but it did not reach statistical significance), while YS1.2 proliferation was not affected by AVE0991 treatment ( Figure 5 C). 3.14.
← all excerpts
Angiotensin 1-7 and the Non-Peptide MAS-R Agonist AVE0991 Inhibit Breast Cancer Cell Migration and Invasion.
1
—
—